Back to trial details

Intake questionnaire

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

Applying to HonorHealth Research Institute · Scottsdale, Arizona

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with PIK3CA Mutations?
3. Are you able to travel to Scottsdale for study visits?